1. Short title This Act may be cited as the Addressing Anti-Competitive Health Care Contract Clauses Act . 2. GAO study (a) Study Not later than 18 months after the date of the enactment of this Act, the Comptroller General of the United States, in coordination with the Federal Trade Commission and the Assistant Attorney General of the Antitrust Division of the Department of Justice, shall carry out a study that— (1) evaluates the effect of anticompetitive contract clauses known as anti-steering clauses, anti-tiering clauses, all-or-nothing clauses, and gag clauses in contracts between health insurers and health care providers, including the effects such contracts have on consolidation in the health care industry, prices paid by consumers for medical services, and consumer access to health care, (2) contains a list of all actions the Federal Trade Commission and the Department of Justice have taken directly or indirectly related to use of such contract clauses in contracts between health insurers and health care providers, (3) contains an assessment of whether the Federal Trade Commission and the Department of Justice have the resources and the capability to effectively enforce the Federal antitrust laws as applied to the use of such clauses in such contracts, and (4) includes recommendations for legislative or administrative actions if necessary to increase such resources. (b) Report The report containing the results of the study carried out under subsection (a) shall be submitted timely by the Comptroller General as follows: (1) To— (A) the Committee on Energy and Commerce, (B) the Committee on Ways and Means, (C) the Committee on Education and the Workforce, and (D) the Committee on the Judiciary, of the House of Representatives. (2) To— (A) The Committee on Health, Education, Labor, and Pensions, and (B) The Committee on the Judiciary, of the Senate. 3. Definitions For purposes of this Act: (1) All-or-nothing clause The term all-or-nothing clause means a provision of a health care contract that requires— (A)